Compounds and pharmaceutical compositions thereof for the treatment of cystic fibrosis
The present invention discloses compounds according to Formula I: ##STR00001## wherein R.sup.1, R.sup.2, R.sup.3, L, and the subscript m are as defined herein. The present invention relates to compounds and their use in the treatment of cystic fibrosis, methods for their production, pharmaceutical compositions, and methods of treatment using the same, for the treatment of cystic fibrosis by administering a compound of the invention.
De Blieck; Ann (Mechelen, BE), De Munck; Tom Roger Lisette (Mechelen, BE), Joannesse; Caroline Martine Andre (Mechelen, BE), Kelgtermans; Hans (Mechelen, BE), Mammoliti; Oscar (Mechelen, BE), Menet; Christel Jeanne Marie (Mechelen, BE), Tricarico; Giovanni Alessandro (Mechelen, BE), Van der Plas; Steven Emiel (Mechelen, BE)
Serving leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.